Aptevo Therapeutics(DE:AP82)
€65,970.000.00 (0.00%)
DE:AP82
Aptevo Therapeutics earnings date
€65,970.00
At close:0.00 (0.00%)
Aptevo Therapeutics (AP82) Q2 2019 Earnings Report
0 Followers
DE:AP82 Q2 2019 EPS Results
- Actual EPS
- -EUR 3.76
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 7.27
DE:AP82 Q2 2019 Revenue Results
- Actual Revenue
- EUR 6.59M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +7.82%
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 08/09/2019
- Time
- Before Open
- Conference Call
- Friday, August 9, 2019
DE:AP82 Upcoming Earnings
Aptevo Therapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AP82 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | ―- | -5.74 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -3.33- | -35.94 | ― | |
| Aug 14, 2026 | 2026 (Q2) | -5.39-4.75 | -135.38 | 96.49% (+130.62) | |
| May 07, 2026 | 2026 (Q1) | -5.01-5.74 | -1415.01 | 99.59% (+1409.27) | |
| Mar 26, 2026 | 2025 (Q4) | ―1508.19 | -2881.59 | 152.34% (+4389.78) | |
| Nov 06, 2025 | 2025 (Q3) | -33.68-35.94 | -5724.51 | 99.37% (+5688.57) | |
| Aug 11, 2025 | 2025 (Q2) | -1340.88-135.38 | -19916.52 | 99.32% (+19781.14) | |
| May 15, 2025 | 2025 (Q1) | -1356.99-1415.01 | -118664.28 | 98.81% (+117249.27) | |
| Feb 14, 2025 | 2024 (Q4) | -2498.03-2881.59 | -160166.96 | 98.20% (+157285.37) | |
| Nov 07, 2024 | 2024 (Q3) | -6797.85-5724.51 | -262373.28 | 97.82% (+256648.78) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

